Find the right fit for you - faster

Get tailored insights about working at BillionToOne in one quick step.

BillionToOne Snapshot

4.4
based on 86 ratings

84% would recommend to a friend

Oguzhan Atay

92% approve of CEO

Mission BillionToOne’s mission is to revolutionize genetic testing through the development of innovative quantitative diagnostics.

BillionToOne's DNA Molecular Counting platform integrates next-generation sequencing technologies with machine learning, which enables noninvasive detection of genetic disorders that are currently only detectable by invasive methods.

BillionToOne is using its platform to develop diagnostics to address the most pressing global health problems.
Description BillionToOne pushes the boundaries of molecular diagnostics through quantitative technologies. Our molecular counter platform is the only technology that can accurately count the DNA molecules at the single base-pair single-count level. This technology increases the resolution of cell-free DNA diagnostics by over 1000-fold and unlocks a wide range of prenatal and oncology applications. Our products are the only tests that can non-invasively detect both single-gene disorders and chromosomal abnormalities.

BillionToOne has raised more than $90M from prominent funds and VCs such as Hummingbird Ventures, Neotribe Ventures, Y Combinator, and Norwest Venture Partners as well as from individual investors who previously invested in SpaceX, Box, and Palantir. BillionToOne is one of top YC Companies: https://www.ycombinator.com/topcompanies/

Life at BillionToOne

Glassdoor gives you an inside look at what it's like to work at BillionToOne, including salaries, reviews, office photos, and more. This is the BillionToOne company profile. All content is posted anonymously by employees working at BillionToOne.